Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan D Glass

Showing results (91-100 of 178) with videos related to

Pageof 18
Sort By:
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 16, 2014
Seeking a measure of clinically meaningful change in ALSMartin McElhiney, Judith G Rabkin, Raymond Goetz, et al.
Journal of Neuropathology and Experimental Neurology|January 31, 2022
Erratum to Letters to the Editor regarding: The Second NINDS/NIBIB Consensus Meeting to Define Neuropathological Criteria for the Diagnosis of Chronic Traumatic Encephalopathy. J Neuropathol Exp Neurol 2021;80(3):210-9Jonathan D Glass, Jennifer L Hammers, Bennet L Omalu, et al.
Annals of Clinical and Translational Neurology|February 6, 2025
ALS plasma biomarkers reveal neurofilament and pTau correlate with disease onset and progressionEleanor V Thomas, Changee Han, Woo Jae Kim, et al.
JAMA Neurology|October 17, 2022
Amyotrophic Lateral Sclerosis Clinical Trials and Interpretation of Functional End Points and Fluid Biomarkers: A ReviewJeremy M Shefner, Richard Bedlack, Jinsy A Andrews, et al.
Annals of Clinical and Translational Neurology|June 22, 2018
Long-term Phase 1/2 intraspinal stem cell transplantation outcomes in ALSStephen A Goutman, Morton B Brown, Jonathan D Glass, et al.
EMBO Reports|June 23, 2022
ALS-linked KIF5A ΔExon27 mutant causes neuronal toxicity through gain-of-functionDevesh C Pant, Janani Parameswaran, Lu Rao, et al.
Acta Neuropathologica Communications|December 19, 2023
Toward a generalizable machine learning workflow for neurodegenerative disease staging with focus on neurofibrillary tanglesJuan C Vizcarra, Thomas M Pearce, Brittany N Dugger, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 9, 2018
An open label study of a novel immunosuppression intervention for the treatment of amyotrophic lateral sclerosisChristina N Fournier, David Schoenfeld, James D Berry, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Molecular Subtyping Based on Hippocampal Cryptic Exon Burden Reveals Proteome-wide Changes Associated with TDP-43 Pathology across the Spectrum of LATE and Alzheimer's DiseaseAdam N Trautwig, Anantharaman Shantaraman, Mingee Chung, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
pTDP-43 levels correlate with cell type specific molecular alterations in the prefrontal cortex of <i>C9orf72</i> ALS/FTD patientsHsiao-Lin V Wang, Jian-Feng Xiang, Chenyang Yuan, et al.
Pageof 18

Showing results (91-100 of 178) with videos related to

Sort By:
Pageof 18
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 16, 2014
Seeking a measure of clinically meaningful change in ALSMartin McElhiney, Judith G Rabkin, Raymond Goetz, et al.
Journal of Neuropathology and Experimental Neurology|January 31, 2022
Erratum to Letters to the Editor regarding: The Second NINDS/NIBIB Consensus Meeting to Define Neuropathological Criteria for the Diagnosis of Chronic Traumatic Encephalopathy. J Neuropathol Exp Neurol 2021;80(3):210-9Jonathan D Glass, Jennifer L Hammers, Bennet L Omalu, et al.
Annals of Clinical and Translational Neurology|February 6, 2025
ALS plasma biomarkers reveal neurofilament and pTau correlate with disease onset and progressionEleanor V Thomas, Changee Han, Woo Jae Kim, et al.
JAMA Neurology|October 17, 2022
Amyotrophic Lateral Sclerosis Clinical Trials and Interpretation of Functional End Points and Fluid Biomarkers: A ReviewJeremy M Shefner, Richard Bedlack, Jinsy A Andrews, et al.
Annals of Clinical and Translational Neurology|June 22, 2018
Long-term Phase 1/2 intraspinal stem cell transplantation outcomes in ALSStephen A Goutman, Morton B Brown, Jonathan D Glass, et al.
EMBO Reports|June 23, 2022
ALS-linked KIF5A ΔExon27 mutant causes neuronal toxicity through gain-of-functionDevesh C Pant, Janani Parameswaran, Lu Rao, et al.
Acta Neuropathologica Communications|December 19, 2023
Toward a generalizable machine learning workflow for neurodegenerative disease staging with focus on neurofibrillary tanglesJuan C Vizcarra, Thomas M Pearce, Brittany N Dugger, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 9, 2018
An open label study of a novel immunosuppression intervention for the treatment of amyotrophic lateral sclerosisChristina N Fournier, David Schoenfeld, James D Berry, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Molecular Subtyping Based on Hippocampal Cryptic Exon Burden Reveals Proteome-wide Changes Associated with TDP-43 Pathology across the Spectrum of LATE and Alzheimer's DiseaseAdam N Trautwig, Anantharaman Shantaraman, Mingee Chung, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
pTDP-43 levels correlate with cell type specific molecular alterations in the prefrontal cortex of <i>C9orf72</i> ALS/FTD patientsHsiao-Lin V Wang, Jian-Feng Xiang, Chenyang Yuan, et al.
Pageof 18